在三阴性乳腺癌中基于非编码RNA的治疗策略:系统性审查
Giovana Prado Scaratti1,2, Inaiê Maiala de Almeida Miranda1,2, Emanuelle Nunes-Souza1,2
1Instituto de Pesquisa Pelé Pequeno Príncipe, Av. Silva Jardim, 1632, Curitiba 80250-060, Brazil.
International journal of molecular sciences
|February 27, 2026
概括
非编码RNAs (ncRNAs) 在治疗三阴性乳腺癌 (TNBC) 方面表现有前途. 在临床前模型中准特定的ncRNA抑制了瘤生长和转移,提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 在RNA治疗方面,RNA疗法.
背景情况:
- 三重阴性乳腺癌 (TNBC) 呈现出显著的异质性,限制了目前的向治疗成功.
- 大多数TNBC患者依赖化疗,突出了需要新的治疗策略.
- 非编码RNAs (ncRNAs) 正在成为TNBC的潜在治疗点.
研究的目的:
- 系统地审查临床前研究,评估在TNBC中准ncRNA的治疗潜力.
- 为了确定特定的ncRNA作为TNBC治疗的可操作目标.
- 在临床前TNBC模型中评估ncRNA调制的疗效.
主要方法:
- 对35项临床前研究 (2020-2025) 关于TNBC中ncRNA向的系统审查.
- 使用体内瘤模型评估治疗反应的研究分析.
- 评估各种ncRNA调制技术 (miRNA模仿,对抗Rs,ASOs,shRNAs,siRNAs) 和传递系统 (纳米粒子,外体).
主要成果:
- 在TNBC中确定了28个特定的ncRNA作为可操作的目标.
- 在临床前模型中,ncRNA调制始终抑制瘤生长和转移.
- 准ncRNAs恢复了对标准化疗剂的敏感性.
结论:
- 临床前证据支持基于ncRNA的疗法作为TNBC治疗的有希望的策略.
- 准ncRNAs提供了一种新的方法来克服TNBC的治疗局限性.
- 进一步开发基于ncRNA的疗法可以显著提升TNBC治疗选择.
相关概念视频
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K